All Posts
RCT | Zolbetuximab plus mFOLFOX6 in CLDN18.2+ HER2- advanced gastric or gastro-oesophageal junction adenocarcinoma
17 Apr, 2023 | 13:00h | UTCZolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial – The Lancet (link to abstract – $ for full-text)
News Release: Results from Astellas’ Phase 3 SPOTLIGHT Trial of Investigational Zolbetuximab Published in The Lancet – PR Newswire
Cohort Study | Cancer surveillance as an alternative to prophylactic total gastrectomy in hereditary diffuse gastric cancer
17 Apr, 2023 | 12:57h | UTCCancer surveillance as an alternative to prophylactic total gastrectomy in hereditary diffuse gastric cancer: a prospective cohort study – The Lancet Oncology (link to abstract – $ for full-text)
Commentary: Endoscopic Surveillance in Patients at Risk for Hereditary Diffuse Gastric Cancer – The ASCO Post
M-A | Efficacy of postpartum pharmacologic thromboprophylaxis
17 Apr, 2023 | 12:55h | UTC
RCT | Safety of Fezolinetant for vasomotor symptoms associated with menopause
17 Apr, 2023 | 12:54h | UTCRelated:
RCT | Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause
RCT | Efficacy of Fezolinetant in moderate-to-severe vasomotor symptoms associated with menopause
The earlier the better: an RCT of treatment timing effects for toddlers on the autism spectrum
17 Apr, 2023 | 12:52h | UTC
RCT | 10-year results show low-dose tamoxifen reduces noninvasive breast cancer recurrence
17 Apr, 2023 | 12:50h | UTCRandomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Recurrence in Breast Noninvasive Neoplasia: A 10-Year Follow-Up of TAM-01 Study – Journal of Clinical Oncology (link to abstract – $ for full-text)
RCT | Hydroxyurea for secondary stroke prevention in children with sickle cell anemia
17 Apr, 2023 | 12:48h | UTC
SR | Blood pressure control for diabetic retinopathy
17 Apr, 2023 | 12:45h | UTCBlood pressure control for diabetic retinopathy – Cochrane Library
Summary: Blood pressure control for diabetic retinopathy – Cochrane Library
SR | Device‐modified trabeculectomy for glaucoma
17 Apr, 2023 | 12:46h | UTCDevice‐modified trabeculectomy for glaucoma – Cochrane Library
Summary: Device-modified trabeculectomy for glaucoma – Cochrane Library
SR | Exercise‐based rehabilitation programs for pulmonary hypertension
17 Apr, 2023 | 12:44h | UTCExercise‐based rehabilitation programmes for pulmonary hypertension – Cochrane Library
Summary: Exercise-based rehabilitation in pulmonary hypertension – Cochrane Library
SR | Mechanical methods for induction of labor
17 Apr, 2023 | 12:42h | UTCMechanical methods for induction of labour – Cochrane Library
Summary: Mechanical methods for induction of labour – Cochrane Library
SR | Inhaled corticosteroids versus placebo for stable chronic obstructive pulmonary disease
17 Apr, 2023 | 12:40h | UTC
SR | Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
17 Apr, 2023 | 12:39h | UTC
SR | Nebulized hypertonic saline solution for acute bronchiolitis in infants
17 Apr, 2023 | 12:37h | UTCNebulised hypertonic saline solution for acute bronchiolitis in infants – Cochrane Library
Review | Diagnosis and management of prediabetes
12 Apr, 2023 | 13:28h | UTCDiagnosis and Management of Prediabetes: A Review – JAMA (free for a limited period)
Editorial: Prediabetes Diagnosis and Management – JAMA (free for a limited period)
Video: Screening for Prediabetes – JAMA
Audio Clinical Review: Diagnosis and Management of Patients With Prediabetes – JAMA
RCT | Doxycycline postexposure prophylaxis effective in preventing gonorrhea, chlamydia, and syphilis in MSM
12 Apr, 2023 | 13:30h | UTCSummary: In this open-label, randomized study involving 501 men who have sex with men (MSM) and transgender women, researchers investigated the effectiveness of postexposure doxycycline in preventing bacterial sexually transmitted infections (STIs), specifically gonorrhea, chlamydia, and syphilis. Participants with a previous STI in the past year, either taking preexposure prophylaxis (PrEP) against HIV or living with HIV, were randomly assigned to receive 200 mg of doxycycline within 72 hours after condomless sex or standard care without doxycycline. STI testing was performed quarterly, with the primary end point being the incidence of at least one STI per follow-up quarter.
Results demonstrated a significant reduction in STI incidence in both the PrEP and persons living with HIV cohorts who received doxycycline. Overall, the combined incidence of these three STIs was lower by two thirds with doxycycline postexposure prophylaxis compared to standard care. The study also reported five grade 3 adverse events but no serious adverse events attributed to doxycycline. This finding supports the use of doxycycline postexposure prophylaxis among MSM with recent bacterial STIs.
Article: Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Doxycycline after sex found to reduce STI incidence in gay men, transgender women – CIDRAP
Commentary on Twitter
In an open-label, randomized study involving men who have sex with men, doxycycline use after high-risk sexual exposure reduced the incidence of sexually transmitted infections (chlamydia, gonorrhea, and syphilis). https://t.co/tYOj8FLEy2 pic.twitter.com/bzNyvwzYS7
— NEJM (@NEJM) April 5, 2023
Cohort Study | Third trimester ultrasound reduces undiagnosed breech presentations
12 Apr, 2023 | 13:27h | UTCCommentary: Timely Ultrasound Can ID Undiagnosed Breech Presentations – HealthDay
M-A | Association of inhaled corticosteroids with all-cause mortality risk in patients with COPD
12 Apr, 2023 | 13:25h | UTCAssociation of Inhaled Corticosteroids With All-Cause Mortality Risk in Patients With COPD: A Meta-analysis of 60 Randomized Controlled Trials – Chest (link to abstract – $ for full-text)
Commentary on Twitter
ICS-based inhaled therapy of longer than 6 months associated with reduction in all-cause mortality risk in patients with #COPD in a meta-analysis of 60 RCTs. Read the full original research in the January issue: https://t.co/p2CwSu8aqb#journalCHEST #MedEd pic.twitter.com/0j24enQmX3
— CHEST® Journal (@journal_CHEST) January 20, 2023
Review | Revised definition of pulmonary hypertension and approach to management
12 Apr, 2023 | 13:22h | UTCRelated:
#ESCCongress | 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
Pulmonary hypertension: An update of Dx and Tx guidelines – Journal of Family Practice
The physiological basis of pulmonary arterial hypertension – European Respiratory Journal
Topic-Based, Recent Literature Review on Pulmonary Hypertension – Mayo Clinic Proceedings
Twenty‐four-hour ambulatory blood pressure profile in patients with reflex syncope vs. matched controls
12 Apr, 2023 | 13:21h | UTC
Cohort Study | Association of the AHA’s new “Life’s Essential 8” with all-cause and cardiovascular disease-specific mortality
12 Apr, 2023 | 13:20h | UTCCommentaries:
Related: Life’s Essential 8: Updating and enhancing the AHA construct of cardiovascular health.
SR | Experiences and perceptions of cash transfers for health
12 Apr, 2023 | 13:23h | UTCSummary: Experiences and perceptions of cash transfers for health – Cochrane Library
ASCO Policy Statement on biosimilar and interchangeable products in oncology
12 Apr, 2023 | 13:18h | UTCASCO Policy Statement on Biosimilar and Interchangeable Products in Oncology – JCO Oncology Practice
Low back pain of disc, sacroiliac joint, or facet joint origin: a diagnostic accuracy systematic review
12 Apr, 2023 | 13:17h | UTC
Guideline | Management of systemic lupus erythematosus
12 Apr, 2023 | 13:16h | UTC


